Overexpression of HER2 in breast cancer cell is found on invasive breast cancer and correlated with worse prognosis. Caesalpinia sappan L shows cytotoxic activity on various cancer cells. The goal of this research is to determine the cytotoxic activity and inhibition of migration and invasion of ethyl acetate fraction of Caesalpinia sappan L. (FEA) on HER2 overexpression-breast cancer cells (MCF-7/HER2). The MTT and flow cytometry assay showed that FEA revealed cytotoxic effect in a dose-dependent manner (IC50= 34 ± 3.1 µg/ml) and induced apoptosis, S and G2/M phase accumulation. Wound healing assay, gelatin zymography and immunoblotting assay showed that FEA inhibited migration and suppressed MMP2, MMP9, HER2 and Rac1 protein level. Thus, ethyl acetate fraction of Caesalpinia sappan L. is potential to be developed on future research especially to treat metastatic breast cancer with HER2 overexpression.
INTRODUCTIONS
Several studies reveal the potential effect of Caesalpinia sappan L. and its compounds for cancer treatment (Kim et al., 2005; Laksmiani et al., 2015; Nirmal et al., 2015; Nurzijah et al., 2012) due to its major compounds. Brazilin and brazilein isolated from Caesalpinia sappan L. inhibit cancer cell growth through inducing of cell cycle arrest and apoptosis on cancer cells (Kim et al., 2012; Tao et al., 2011 Tao et al., , 2013 . Moreover, brazilein also inhibit migration of cancer cells, MDAMB-231 (Hsieh, et al., 2013) . Migration and invasion are the important processes in early step of metastasis event (Brooks et al., 2010) . Thus, Caesalpinia sappan L. shows a promising anticancer agent targeted on the inhibition of proliferation and metastasis.
The ErbB2/HER2 (epidermal growth factor receptor 2) is a member of the epidermal growth factor receptor (EGFR) that is observed abundant in many human cancers especially breast cancer and related with invasive, drug resistance and poor prognosis. ErbB2 is also believed as a biomarker for invasive breast cancer, hence a potential therapeutic target (Brix et al., 2014) . Once HER2 receptor activated, it transduces intraselluler signals through several signaling cascades, including MAPK and NF-κB activation to induce cells proliferation and migration (Knuefermann et al., 2003; Merkhofer et al., 2010) . Overexpression HER2 increases maintaining of Src activation resulting in MAPK activation through Raf Kinase to activate cells proliferation. In other event, activation of Src together with p120 catenin (p120) and Vav2 activates small RhoGTPase protein (Rac1,cdc42 and RhoA) and modulate cell migration (Johnson et al., 2010) . However, down regulation of Rac1 protein expression reduces the migration and invasion potential of cancer cells (Chen et al., 2011) . Hence, inhibition of HER2 mediated-signaling pathways is essential to abrogate the proliferation and metastasis of HER2 overexpressing cancer cells.
In our previous result showed that ethanolic extract of C. sappan performed inhibitory effect on MCF7 and 4T1 breast cancer cells (Handayani et al., 2016) .
*Corresponding author e-mail: meiyan_e@ugm.ac.id Jenie et al. ISSN: 2088 -0197 e-ISSN: 2355 Ethanolic extract suggest to contain too many compounds, whereas, brazilin and brazilein as well as other major phenolic compounds thought to contribute significantly in the cytotoxic effect against cancer cells (Kim et al., 2012 (Kim et al., , 2005 Laksmiani et al., 2015; Nurzijah et al., 2012) . It is well known that some phenolic compounds, including brazilein and brazilin, in ethanolic extract can be fractionated by ethyl acetate solvent to obtain a purified extract (Nirmal et al., 2015) . The purified extract is valuable to be used in phytomedical practices due to the more concentrated active compounds with less abundant material and easier to achieve chemically standard reliability. Therefore, the purpose of this research is to explore the effect of ethylacetate fraction of C. sappan on metastatic human breast cancer cells especially in HER2 overexpressed breast cancer cells focusing on its proliferation and migration.
MATERIALS AND METHODS

Preparation of samples
Dried heartwoods powder of Caesalpinia sappan L. was obtained from B2P2TOOT Tawangmangu, Indonesia. Dried powder was extracted in methanol to get methanol extract. The methanol extract was diluted by methanol: water (4:1) and then partitioned with hexane. The aqueous layer was fractioned with ethyl acetate and concentrated with vacuum rotary evaporator to get fraction of ethyl acetate (FEA).
Cell culture
MCF-7/HER2 and MCF-7/empty factor (MCF-7/Mock) cell line were kindly given from Prof.Dr. Yoshio Inouye through Prof. Dr. Mashashi Kawaichi (NAIST, Japan) and were cultured in CO2 incubator (37ᵒC) with Dulbecco's Modified Eagle Medium (DMEM) medium (Gibco) contained 10% Fetal Bovine Serum (Gibco), 1.5% PenicillinStreptomycin (Gibco) and 0.5% fungizone (Gibco). MDAMD-231 cell line was kindly given from Prof. Dr. Mashashi Kawaichi (NAIST, Japan) and was cultured in non-CO2 incubator (37ᵒC) with L-15 medium (Sigma) contained 15% Fetal Bovine Serum (Gibco), 1.5% Penicillin-Streptomycin (Gibco) and 0.5% fungizone (Gibco). 
Cell cycle distribution
Propidium iodide (PI) staining kit (Becton Dickinson) was used to analyze DNA content. Cells were seed ed in 24-well plates with 5x10 4 within 24-48 h (to yield 60-70% confluence). Cells were treated with ½ IC50 of sample. After a 24-h treatment, cells were harvested, and the cells were resuspended in PBS, fixed with 70% ethanol, labeled with PI (2 µg/mL), and incubated at room temperature in the dark for 10 min. DNA content was analyzed using a Flow cytometry (Becton Dickinson) and followed by flowing software (version 2.5.1).
Apoptosis detection
Apoptotic population was determined by PI-Annexin V assay (Annexin V-FITC Apoptosis Detection Kit Roche). Cells were seeded in 24-well plates with 5x10 4 within 24-48 h (to yield 60-70% confluence). Cells were treated with ½ IC50 of sample. After a 24-h treatment, cells were harvested, added with 1x binding buffer, labeled with PI-Annexin V, and incubated at room temperature in the dark for 5 min. Then the cells suspension wa s analyzed using a Flow cytometry (Becton Dickinson).
Wound healing assay
Cells were seeded in each well of 24-well plate with 1×10 5 cells and incubated at 37ᵒC in CO2 incubator for 24h. Thereafter cell were starved by using serum free-medium (containing 0.5% fetal bovine serum) for 24 h. The confluent cell monolayers were wounded by a yellow-tip. After washing once with PBS, ISSN: 2088 -0197 e-ISSN: 2355 the cells were added with DMEM culture medium which contained of 1/4 IC50 of sample. Time-lapse images were acquired at 0, 18, and 24 h. Percent of closured were analyzed by using Image-J software.
Gelatin zymography
MMP-9 and MMP2 activity was assayed by gelatin zymography. Cells were seeded in each well of 6-well plate with 1×10 6 cells and incubate at 37ᵒC in CO2 incubator for 24h. Cells were incubated with 1/4 IC50 of sample in serum free-medium for 24 h. The supernatants were collected and subjected to gel electrophoresis on 10% running gel containing 0.1% gelatin. The gel were washed in renaturing solution containing 2.5% Triton x-100 for 30 min, and followed by incubation for 20 h at 37ᵒC with incubation buffer. The gels were stained for 30 min in 0.5% commassie brilliant blue and destained with destaining solution (10% v/v methanol and 5% v/v acetic acid). After that, gel were scanned and documented.
Immunoblotting
Cells were seeded in 10 cm cultured dish with 1×10 6 cells and incubate at 37ᵒC in CO2 incubator for 24h. Cells were incubated with ¼ IC50 of sample for 24 h. Cell were collected with RIPA buffer (25 mM Tris-HCl at pH 7.6, 150 mM NaCl, 1% NP-40, 1% deoxycholic acid-Na, 0.1% SDS, proteases and phosphatase inhibitor cocktail). Protein samples were obtained using Bradford method and were measured by microplate reader (SH-1000, Corona electric), separated by electrophoresis on 7-15% SDS polyacrylamide gel electrophoresis (PAGE) gels, and electrotransferred onto PVDF transfer membranes (Immobilon, millipore). After blocking with 1x NET gelatin, the membranes were probed with antibodies for HER2 (sc-52349), p120 (sc-13957) and ß-actin (sc-47778, Santa Cruz Biotechnologies, Santa Cruz, CA), and Rac-1 (ab 33186, Abcam), then exposed to horseradish peroxidase (HRP)-conjugated secondary anti-mouse (sc-2031, Santa Cruz Biotechnologies, Santa Cruz, CA) or antirabbit antibodies (cs-7074P2, Cell signaling). Protein expression was examined using the enhanced chemiluminescence (ECL) system (Amersham).
Statistical analysis
Data were presented as the mean ± standard deviation (SD). The statistically significant differences between the control/ untreated group and treated groups were analyzed by Student t-test. Mean differences was significant at the P<0.05. Firstly, it is important to confirm the cytotoxic activities of FEA on both MCF-7/Mock and MCF-7/HER2 cells. Treatment of FEA induced the morphologycal alteration of MCF-7/HER2 cells (Fig. 1A) as well as MCF-7/Mock (data not shown). The FEA inhibited MCF-7/Mock and MCF-7/HER2 cells growth with IC50 value 28 ± 1.3 µg/ml and 33.5 ± 3.1 µg/ml (Fig. 1B-C) respectively. In order to investigate the mechanism of the cytotoxic effect of FEA, we observed the effect of FEA on cell cycle modulation and induction of apoptosis in the further study. Cell cycle analysis by using flow cytometry showed that treatment of 17.5 µg/ml FEA for 24 h caused increasing of sub-G1, Sphase and G2/M-phase accumulation until 20.2%, 4.5%, and 2.7% respectively compared to untreated cells ( Fig. 2A-B) . The high cells accumulation on sub-G1 phase represents the death cells. Nevertheless, to investigate that the death cells were due to apoptosis induction, it should be confirmed with PI-Annexin V flowcytometry analysis. We proved that FEA treatment induced total apoptosis up to 18.4% compared to untreated cells (Fig. 2C-D) . Cytotoxic activity of FEA possibly through inducing of apoptosis and cells cycle accumulation in S-phase and G2/M-phase. Cells were scratched according to wound healing assay, were treated with 28.75 µg/ml FEA and were photographed at 0, 18, 24, and 42 h. B. MMP9 and MMP2 activity on MCF-7/HER2. Cells were treated with 8.75 µg/ml FEA for 24 h and were observed by gelatin zymography. C. Graphic of MMP9 and MMP2 activity. Analysis of activity level of MMP9 and MMP2 was calculated by using image J software, Data was collected from three replications (*P<0.05).
To study whether FEA inhibit migration and invasion, we tested the effect of FEA by wound healing assay and gelatin zymography. We used MDAMB 231 cells as a model for wound healing assay. The result showed that FEA inhibited wound closured on MDAMB 231 cells after 18 and 24 h incubation (Fig 3A) . MMP2 and MMP9 protein on microenvironment of cancer cells were important markers for migration and invasion cells. Furthermore, we tested the effect of FEA on MMP2 and MMP9 protein expression of MCF-7/HER2 cells based on MMP2 and MMP9 activity by using gelatin zymography. Treatment of FEA decreased MMP2 and MMP9 activity level on MCF-7/HER2 cells until 16% and 30% respectively (Fig 3B-C) . Based on the results, FEA inhibited migration and invasion on metastatic cancer cells.
Inhibition of HER2 and Rac1 protein expression
The HER2 pathway has an important role on migration and invasion of breast cancer cells. In this study, we observed the effect of FEA on modulation of HER2 protein expression on MCF-7/HER2. The result showed that FEA decreased HER2 protein level (Fig. 4) . The p120 is co-regulator that has an important role on Rac1 activation through HER2 signaling pathway (Johnson et al., 2010) . We also observed the effect of FEA on p120 and Rac1 protein expression that have a role on migration. The MCF-7/HER2 cells showed high level of p120 protein expression but had no effect after FEA treatment (Fig 4) . On the other hand, FEA decreased Rac1 protein level compared to untreated cells (Fig.  4) . The FEA decreased HER2 and Rac1 protein level compared to untreated cells. 
DISCUSSIONS
The development of antimetastatic agents from natural origin continuously is needed due to the complexity of metastatic feature of cancer cells. Here, we demonstrated C. sappan ethyl acetate fraction to inhibit metastatic breast cancer cells proliferation and migration. We found that FEA inhibit MCF7/HER2 cells as well as MCF7/Mock cells (Fig.1) . The differences of the IC50 values were not so wide, indicating that the two different cells character seemed to be responsive to FEA. This phenomenon indicates that FEA is possibly developed to treat breast cancer with high level of HER2.
We also found that FEA performed strong inhibitory effect to the cells migration in MDAMB231 cells. This is an interesting finding since the mature cancer cells tend to be malignant phenotype with metastasis characteristic. MDAMB cells are human metastatic cancer cells through MAPK signaling and exhibit medium HER2 expression (data not shown). However, whether FEA inhibits the cells migration through inhibition of MAPK has to be explored further, even in previous study suggest that brazilein inhibit NF-κB activation through inhibition of IKK (Hsieh et al., 2013) . Moreover, we found that FEA inhibited HER2 expression indicating that there were possibly a correlation between the inhibitory effect on NF-κB activation and the lowering HER2 expression since NF-κB is known as transcriptional regulatory protein of HER2.
Rac-1 and p120 are well known as the key regulators of HER2 overexpression-cells migration (Johnson et al., 2010) . Our findings suggest that FEA more affected to the Rac-1 expression rather than p120. These findings correlate to the inhibitory effect of cells migration indicating that the inhibitory effect of HER2 expression may correlate to the downregulation of Rac-1 expression but not p120 and contribute to the inhibition of cells migration. This phenomenon is rather unique because it shows different evidence in which Rac-1 expression correlate with p120 level in HER2 expressing cells (Johnson et al., 2010) . Hsieh et al. (2013) reported that brazilein inhibits migration through inhibition of PI3K and MAPK pathway leading to inhibition of NF-κB activation. Overexpression HER2 activates NF-κB (Merkhofer et al., 2010) . Rac-1 protein is also activated through PI3K pathway (Ridley, 2015) . Further study focusing on Rac-1 activation and expression in correlation with NF-κB activation will elucidate more detail to these phenomena.
Overall, our finding suggests that FEA is potential to be developed as antimetastatic cancer with or without HER2 overexpression. This suggestion is also supported by the fact that FEA treatment decreased the expression of MMP9 and MMP2 significantly. MMP9 and MMP2 are extracellular enzymes secreted by the cells in which the expression levels were regulated by NF-κB activation (Hsieh et al., 2013; Kim, 2010) . Our findings provide information the possible inter-correlation among HER-2 status, Rac1, MMP9, MMP2 and NF-κB activation. Further investigation to elucidate this phenomenon is interesting to gain the platform of this fraction to be used in phytomedical practices, especially to cure cancer metastasis in co-chemotherapeutics application.
CONCLUSIONS
This study confirms that FEA inhibits cell proliferation and migration on MCF-7/HER2 breast cancer cells possibly due to down regulation of MMP9, MMP2, HER2 and Rac1 protein expression.
